Repurposed Alzheimer’s medication provides new glioblastoma treatment
Exciting new research has identified that a drug previously prescribed for Alzheimer's disease may work as an effective glioblastoma treatment.
An investigation conducted by Cleveland...
UK first to approve antiviral pill for COVID-19
The antiviral pill known as Lagevrio (molnupiravir) has now been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in the...
Blood clot-dissolving drug employed as innovative stroke treatment
A team of UK-based researchers have devised a novel stroke treatment that has demonstrated effectiveness in combatting blood clots.
Scientists from the University of Manchester...
Ebola vaccine by University of Oxford to begin human trials
The University of Oxford has begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers against Zaire and Sudan...
Pancreatic cancer immunotherapy enhanced by new experimental drug
A team of researchers has identified a novel experimental drug that effectively boosts the efficacy of pancreatic cancer immunotherapy, potentially a landmark breakthrough in...
Innovative new glaucoma treatment could help millions worldwide
Findings from a Northwestern Medicine study have potentially produced an effective glaucoma treatment – a significant advancement in combatting the condition.
The Northwestern University Fienberg...
WHO: Distribution crucial to malaria vaccine success
In an exciting development for modern medicine, the World Health Organization (WHO) announced last week that it recommends the rollout of the world's first...
Vaccine cold chain pioneers inaugurate new factory extension
Luxemburg-based vaccine cold chain specialists B Medical Systems have conducted the opening ceremony of their cutting-edge factory extension at its corporate headquarters.
The factory extension...
Defence Therapeutics embark on next stage of breast cancer treatment development
In a groundbreaking development, pioneering biotechnology company Defence Therapeutics has announced today it will be performing the final necessary studies before entering a Phase...
A new hope for treating neurodegenerative diseases
NervGen’s NVG-291 is a new drug with the potential to treat a range of neurodegenerative diseases, including Alzheimer's and MS.
IT is the Holy Grail...
Defence Therapeutics’ new COVID vaccine achieves successful testing
Biotechnology experts Defence Therapeutics have sensationally announced that their new COVID vaccine has demonstrated effectiveness in a non-rodent model.
The new COVID vaccine – called...
Defence Therapeutics unveil novel HPV vaccine development programme
Industry-leading biotechnology company Defence Therapeutics has revealed that it will be establishing a high priority programme to develop a new HPV vaccine for cervical...
Versatile Accum technology for various immune-oncology needs
Defence Therapeutics explains how its Accum™ technology can enhance the delivery of tumour and infectious disease-specific therapeutics.
The principal technology developed by Defence Therapeutics (DT)...
Viagra shown to suppress abnormal heart rhythms
The drug sildenafil, sold under the brand name Viagra, can strongly suppress abnormal heart rhythms, a new study has found.
In a study led by...
Cancer vaccine developed using Oxford-AstraZeneca vaccine technology
Scientists are utilising the same technology used in the creation of the Oxford-AstraZeneca COVID-19 jab to develop a vaccine to treat cancer.
Researchers at the...
Researchers issue opioid warning as they reveal overdose findings
Hundreds of patients could have died from an accidental overdose of prescription opioids, the findings from a recent study have revealed.
Research led by Dr...
Pfizer-BionNTech vaccine side effects mild to moderate in high-risk children
The side effects of the Pfizer-BionNTech vaccine in clinically vulnerable 12- to 15-year-olds are likely to be minimal, a study has shown.
In a small...
$1.5m funding will further research towards TB vaccine
The VALIDATE Network has received a $1.5m funding boost to support its development of a tuberculosis (TB) vaccine.
The Bill & Melinda Gates Foundation have...
COVID-19 vaccine benefits outweigh risk of Bell’s palsy, say researchers
The benefits and efficacy of COVID-19 vaccines far outweigh the minimal risk of developing Bell’s palsy, researchers have said.
Following the first large-scale population-based study...
Pre-clinical trials show intranasal COVID-19 vaccine reduces infection risk
Researchers have made a significant breakthrough in the development of an intranasal COVID-19 vaccine.
Scientists from Lancaster University have carried out pre-clinical trials of a...
